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Summary A simple and quick way of discrimination between cardiac and pulmonary
causes of dyspnea is essential in patients admitted to the emergency department. We
aimed to assess the utility of easily applicable diagnostic tools in the differential
diagnosis of cardiac and pulmonary causes of dyspnea in patients presenting with
shortness of breath. Clinical and radiologic evaluation, peak expiratory flow (PEF),
PaO2, PaCO2 measurements were performed in 94 patients admitted to the
emergency room with dyspnea. All the patients were hospitalized for accurate
diagnosis and later were categorized into cardiac and pulmonary dyspnea groups. PEF,
%PEF (percent of predicted PEF), dyspnea differentiation index (DDI¼ PEF PaO2 /
1000), %DDI (% PEFPaO2/1000), PaO2 and PaCO2 measurements were compared
between the two groups. When cardiac and pulmonary dyspnea groups were
compared, considering 1.6 as the cut-off value for DDI, measurements above this
value imply cardiac pathology with 76.7% sensitivity and 67.2% specificity. The
sensitivity and specificity for cardiac dyspnea calculated according to the cut-off
values were 96.7% and 40.6% for %DDI; 86.7% and 60.9% for PEF; 86.7% and 54.7% for
%PEF; 66.7 and 68.7 for PaO2. Also for pulmonary dyspnea, sensitivity and specificity
values for PaCO2 were 50% and 93%.
We conclude that DDI, %DDI, PEF, %PEF, PaO2 and PaCO2 are simple and easily
applicable tools for differential diagnosis of cardiac and pulmonary dyspnea.
Adjunctive utility of these tests in the emergency department with clinical and
radiologic evaluation contributes to this discrimination.








Many patients admitted to the emergency depart-
ment present with shortness of breath. In the
absence of additional clinical findings, discrimina-
tion between cardiac and pulmonary causes of
dyspnea is difficult. As most of the clinical findings
in cardiac failure are related to pulmonary involve-
ment, physical findings are usually similar in both
conditions.1 The differences of the treatment
strategies in pulmonary and cardiac diseases and
probability of worsening of the primary disease
with wrong treatment modality necessitates early
and correct diagnosis. On the other hand, insuffi-
ciency of clinical and even radiologic evaluation
with respect to differential diagnosis reveals the
need of simple, non-invasive and cheap diagnostic
tools.2,3 In previous studies, PEF, end-tidal carbon
dioxide, arterial blood gas analysis were investi-
gated but exact cut-off values could not be
obtained. In a study conducted in 1999, DDI and
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%DDI were found to be easy and cheap methods to
be used in differential diagnosis.4
In this study, we aimed to investigate the
contribution of PEF, %PEF, PaO2, PaCO2 DDI and
%DDI to the differential diagnosis of cardiac and
pulmonary dyspnea.
Methods
Included were 94 patients (36 female and 58 male)
who were admitted to the emergency department
of Dr. L .utfi Kirdar Kartal Education and Research
Hospital in 2001. The patients presented with
dyspnea. All were hospitalized for further diagnosis
and treatment. Patients having both cardiac and
pulmonary diseases were excluded from analysis.
All the patients had moderate, severe or very
severe dyspnea (grade 2–4) according to ATS
dyspnea classification.5
The patients were first evaluated by the emer-
gency department physician with history and
physical examination followed by PEF, PaO2, PaCO2
measurements. Arterial blood gases were drawn
from radial or femoral arteries prior to medical
treatment and oxygen therapy. PEF was measured
before treatment by using ‘‘peak flow meter’’(Fer-
raris pocket PEAK-Ferraris Medical Ltd.) and the
highest value of 3 consecutive attempts was
recorded. Patients exposing insufficient coopera-
tion were excluded. To combine the effects of PEF
and PaO2, new parameters DDI, the product of
PEF PaO2 divided by 1000 and %DDI, the product
of %PEF PaO2 divided by 1000 were calculated.
%PEF was calculated according to predicted values
(% PEF¼measured PEF/predicted PEF 100).6
After this evaluation, patients were hospitalized
in the Chest Diseases Department. Six patients
diagnosed with myocardial infarction (MI) were
internalized in Coronary Intensive Care Unit. With
further assessments (lung function tests, electro-
cardiography, echocardiography, radiologic investi-
gations) the cause of dyspnea was revealed and two
categories were formed: Cardiac and pulmonary
causes of dyspnea. Means of PEF, PaO2, PaCO2, DDI
and %DDI values were calculated in both groups.
Mann–Whitney U test was used for data analysis
and Po0:05 was considered significant. Optimal
cut-off values were calculated using receiver
operating characteristics (ROC) curve analysis for
PEF, %PEF, DDI, %DDI, PaO2 and PaCO2 measure-
ments and sensitivity, specificity, negative and
positive predictive values were calculated.
Results
In 94 patients who presented with dyspnea and
hospitalized for further investigation, 64 were
found to have pulmonary causes of dyspnea
whereas 30 had dyspnea of cardiac origin. Mean
age was 54 (range 16–76) years for pulmonary
group and 61 (range 32–77) years for cardiac group
(Table 1). In the group of cardiac origin the mean
age and the test results were similar for congestive
hearth failure (CHF) and MI. Also two leading
subgroups (COPD and asthma) of the pulmonary
origin were similar with respect to the mean age
and other test results. All parameters had statisti-
cally significant differences between cardiac and
pulmonary dyspnea groups, with DDI and %DDI being
the most prominent (Table 2). According to optimal
cut-off values calculated by using ROC curve
analysis (Fig. 1), %DDI showed highest sensitivity
for cardiac dyspnea whereas PaCO2 was found
to be the most specific test for pulmonary dyspnea
(Table 3).
The optimal cut-off values were 1.6 for DDI; 0.3
for %DDI; 170 l/min for PEF; 37.5 for %PEF; 8.9 kPa
for PaO2 and 5.6 kPa for PaCO2. DDI, %DDI, PEF,
%PEF and PaO2 measurements above the cut-off
value remind of cardiac pathology. On the other
hand, PaCO2 above 5.6 kPa implies pulmonary
pathology with 50% sensitivity and 93% specificity.
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Table 1 Distrubition of the diseases causing dyspnea.
Pulmonary origin N Agea Cardiac origin N Agea
COPD 31 59.6710.3 (33–76) CHF 24 61.1711.2 (32–77)
Asthma 21 50.5718.1 (16–75) AMI 6 63.777.4 (53–72)
Pneumonia 6 50.5720.9 (24–72)
Interstitial lung disease 4 48.7723.7 (22–72)
Lung carcinoma 2 37.5729 (17–58)
Total 64 54.4716.1 (16–76) 30 61.6710.5 (32–77)
COPD: Chronic obstructive pulmonary disease. CHF: Congestive heart failure. AMI: Acute myocardial infarction.
aMean age7SD, range in paranthesis
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Discussion
Pulmonary function tests have been used in the
differential diagnosis of dyspnea of cardiac vs.
pulmonary origin, for a long time. Previous studies
have proved that PEF correlates well with FEV1
which implies large airway obstruction and should
therefore be considered during differential diag-
nosis.7,8
In the early phases of pulmonary edema caused
by CHF, there is small airway obstruction due to
peribronchial and interstitial edema and engorged
vascular structures. Large airway obstruction af-
fecting PEF and FEV1 does not occur unless the
disease progresses.9–11 Hales et al. applied pul-
monary function tests to 78 patients with recent
myocardial infarction without detectable conges-
tion and obtained normal PEF values in the first
week. At examination after 1 week slight increases
in PEF measurement were recorded.10 Enright et al.
detected reduced FEV1 and FVC in elderly persons
with hypertension, ischemic heart disease and
congestive heart failure.11 Decrement in PEF is
expected to be more prominent in pulmonary
diseases. PEF, reflecting the obstruction of large
airways can therefore be used in differential
diagnosis of cardiac and pulmonary diseases.
McNamara et al. noted significantly different
PEF measurements between pulmonary and
cardiac groups, with slightly reduced values
in cardiac group compared to the normal popula-
tion. They also propose that there is no single
value allowing 100% accuracy, but a PEF value
above 150 l/min is suggestive of cardiac disease
with 78% sensitivity and 87% specificity, while a
reading p150 l/min suggests a diagnosis of pul-
monary disease with 87% sensitivity and 78%
specificity.9
We obtained statistically significant difference in







































































Using %DDI Using PEF
Using %PEF Using PaO2 Using PaCO2
Figure 1 ROC curves of DDI (a), %DDI (b), PEF (c), %PEF (d), PaO2 (e) and PaCO2 (f) DDI: Dyspnea differentiation index
(PEF PaO2/1000) %DDI¼%PEFPaO2/1000.
Table 2 Mean7SD values of all parameters for pulmonary and cardiac groups.
Pulmonary origin Cardiac origin P
DDI 1.671.2 2.471.8 0.000
%DDI 0.470.2 0.570.3 0.000
PEF (l/min) 186.27108.8 253.3793.7 0.001
%PEF 43.0720.0 56.0721.8 0.002
PaO2 (kPa) 8.372.3 9.471.7 0.008
PaCO2 (kPa) 6.072.1 4.970.6 0.006
DDI: Dyspnea differentiation index (PEF PaO2/1000). %DDI¼ %PEF PaO2/1000.
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values above cut-off value of 170 l/min to imply
cardiac pathology with 86.7% sensitivity and 60.9%
specificity. On the contrary, PEF measurements
below the cut-off value imply dyspnea of pulmon-
ary origin with 60.9% sensitivity and 86.7% specifi-
city. Considering %PEF values, results above
37.5% remind of cardiac pathology with an 86.7%
sensitivity.
Hypoxemia is a frequent finding in patients
presenting with dyspnea and may occur with
different mechanisms such as ventilation/perfusion
mismatch, shunt, dead space ventilation and
diffusion abnormalities. Hypoventilation and venti-
lation/perfusion mismatch in COPD and asthma,
bronchoconstriction due to cytokines secreted from
inflammatory cells in pneumonia, diffusion abnorm-
ality in interstitial lung diseases are thought to
result in low PaO2. On the other hand, considering
the cardiac diseases, severe hypoxemia is not
expected unless congestive failure causing severe
pulmonary edema exists. Nevertheless, ventila-
tion/perfusion mismatch or decreased PaO2 and
increased alveoloarterial O2 gradient due to shunt
effect may occur.10 Fillmore et al. documented
PaO2 in MI patients and found 11.971.2 kPa in the
absence of clinical signs of congestive failure (Class
I), 11.071.3 kPa in Class II where there was mild
congestion, 9.471.1 kPa in Class III where there
was pulmonary edema and finally 8.070.9 kPa in
severe cardiac failure (Class IV).12 Ailani et al.
found statistically significant differences in PaO2,
when they compared cardiac and pulmonary
groups.4 In our study, we found significantly higher
values of PaO2 in the cardiac dyspnea group and
concluded that PaO2 values above 8.9 kPa are 66.7%
sensitive and 68.7% specific in differential diagnosis
of cardiac dyspnea.
When dyspnea of cardiac origin is considered,
even in the presence of pulmonary congestion,
PaCO2 measurements are normal or low. In spite of
the fact that dead space ventilation is increased,
pH is slightly alkaline. In severe pulmonary edema
PaCO2 is seldom found to be increased.
10 Fillmore
recorded PaCO2 values of 5.270.8 kPa even in
cardiogenic shock.12 However, increase in PaCO2
and respiratory acidosis are frequent arterial blood
gas findings in pulmonary diseases with alveolar
hypoventilation. In our study, mean values for
PaCO2 were 6.072.1 and 4.970.6 kPa in pulmonary
and cardiac groups respectively; showing a statis-
tically significant difference. Thirty-one COPD
patients in 64 pulmonary dyspnea cases were
thought to contribute to this result. Fifty percent
sensitivity and 93% specificity would be obtained
for pulmonary disease if the cut-off value of PaCO2
was 5.6 kPa.
In 1999, Ailani et al defined a new measure, DDI
as (PEF PaO2)/1000 and %DDI, (%PEF PaO2/
1000). They concluded that DDI and %DDI had
higher sensitivity and negative predictive value
than PEF and %PEF.4
In our study, we used these two recently
described parameters and found cardiac diseases
to have 76.7% sensitivity and 67.2% specificity with
a cut-off value of 1.6 for DDI. Considering %DDI
values cardiac pathologies had 96.7% sensitivity and
40.6% specificity, using a cut-off level of 0.3.
Comparing all the parameters used between two
groups, most significant difference was calculated
for DDI and %DDI.
In this study, we found %DDI to have the highest
sensitivity and PaO2 to have the highest specificity
for dyspnea of cardiac origin. Cut-off level is 0.3 for
%DDI and values above that had 96.7% sensitivity,
cut-off level for PO2 is 8.9 kPa and values above this
have 68.7% specificity for cardiac dyspnea. More-
over, PaCO2 above 5.6 kPa notifies pulmonary
dyspnea with a specificity of 93%.
In conclusion, PaCO2, PaO2, DDI, %DDI, PEF and
%PEF are easily available adjunctive tools in
differential diagnosis of dyspnea of pulmonary vs.
cardiac origin.
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Table 3 Optimal cut-off values, sensitivity, specificity, negative and positive predictive values of DDI, %DDI, PEF,











DDIa 1.6 76.7 67.2 52.3 86
%DDIa 0.3 96.7 40.6 43.3 93.3
PEF (l/min)a 170 86.7 60.9 51 90.7
%PEFa 37.5 86.7 54.7 47.3 89.7
PaO2 (kPa)
a 8.9 66.7 68.7 50 81.5
PaCO2 (kPa)
b 5.6 50 93 94.1 46.7
aSensitivity, specificity, negative and positive predictive values for cardiac dyspnea above cut-off value.
bSensitivity, specificity, negative and positive predictive values for pulmonary dyspnea above cut-off value
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